' Paradigm Shift ' : Luspatercept for MDS ' Paradigm Shift ' : Luspatercept for MDS

Luspatercept showed significant improvement over erythropoiesis-stimulating agent epoetin alfa in reducing dependency on red blood cell transfusions in patients with LR-MDS who are ESA naive.MDedge News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news